Nordic Pharma Consulting ApS
CVR 37368598 · Private limited company (ApS) · Active · Low risk
Nordic Pharma Consulting ApS is a Private limited company (ApS), founded on , based in Bagsværd. The company is registered in the industry virksomhedsrådgivning og anden ledelsesrådgivning. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.1 times the average for Danish companies. 10 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 4.5m and a net result of DKK 3.7m. CEO: Ray David Sossna.
Bankruptcy risk for Nordic Pharma Consulting ApS
0.1 × the average (1.41%) · higher risk than 38% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 37368598
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (10 years)
- Address
- Ullasvej 7B
2880 Bagsværd - Municipality
- Gladsaxe
- Industry
- Virksomhedsrådgivning og anden ledelsesrådgivning (702000)
Bankruptcies in the industry: Virksomhedsrådgivning og anden rådgivning om driftsledelse - Share capital
- DKK 50k
- Employees
- 6 (2018)
- Auditor
- REDMARK, GODKENDT REVISIONSPARTNERSELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 10 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 56.6% |
| Current ratio | 231% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 1 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 3 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK 15.9m | DKK 14.1m |
| Net profit | DKK 3.7m | DKK 3.0m |
| Equity | DKK 4.5m | DKK 3.8m |
| Total assets | DKK 7.9m | DKK 8.1m |
| Cash | DKK 2.6m | – |
| Short-term debt | DKK 3.4m | – |
| Avg. employees | 10 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · Redmark, Godkendt Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 120 | ||
| 1 Jan 2024 – 31 Dec 2024 | 161 | ||
| 1 Jan 2023 – 31 Dec 2023 | 136 | ||
| 1 Jan 2022 – 31 Dec 2022 | 117 | ||
| 1 Jan 2021 – 31 Dec 2021 | 109 | ||
| 1 Jan 2020 – 31 Dec 2020 | 96 | ||
| 1 Jan 2019 – 31 Dec 2019 | 105 | ||
| 1 Jan 2018 – 31 Dec 2018 | 67 | ||
| 1 Jan 2017 – 31 Dec 2017 | 152 | ||
| 14 Jan 2016 – 31 Dec 2016 | 149 | Restated |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Ray David Sossna | Current | |
| Owner (50%) | Bill Holding ApS | Current | |
| Owner (33%) | by.david ApS | Current | |
| Auditor | REDMARK, GODKENDT REVISIONSPARTNERSELSKAB | Current | |
| Auditor | 18. juni 2024 P/S | ||
| Founder | Bill Holding ApS | Current |
The CEOs' other companies
Ray David Sossna – 1 other companies
- by.david ApS Active
Address history (0 moves)
| Ullasvej 7B, 2880 Bagsværd |
Employees per year
Other companies at the same address
- Bill Holding ApS Active
- Gopal Holding ApS Active
- Streamline360 ApS Active
Similar companies in Gladsaxe
- GEERT SAABY JENSEN ApS Bagsværd
- Designed Systems ApS Søborg
- Nordlys Horisont ApS Søborg
- Votra Business ApS Søborg
- CForsingdal consulting ApS Søborg
- MR PRO ApS Kongens Lyngby
- Møller Pro ApS Kongens Lyngby
- ravihyatt ApS Søborg
- PGötzsche ApS Bagsværd
- iLEADish ApS Søborg
- Mars53 ApS Søborg
- Bifrost Partners ApS Gentofte
Questions and answers about Nordic Pharma Consulting ApS
Has Nordic Pharma Consulting ApS gone bankrupt?
No, Nordic Pharma Consulting ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Nordic Pharma Consulting ApS?
Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.1 times the average for Danish companies.
Who is the CEO of Nordic Pharma Consulting ApS?
Ray David Sossna is the CEO of Nordic Pharma Consulting ApS.
Who is the auditor of Nordic Pharma Consulting ApS?
Nordic Pharma Consulting ApS most recently used REDMARK, GODKENDT REVISIONSPARTNERSELSKAB.
When was Nordic Pharma Consulting ApS founded?
Nordic Pharma Consulting ApS was founded on 14 January 2016.
What is the equity of Nordic Pharma Consulting ApS?
Equity was DKK 4.5m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.